-
5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]-N-({[3-(2-{2-[3-amino(1,1,2,2-2H4)propoxy]ethoxy}ethoxy)(2,2,3,3-2H4)propyl]carbamoyl}methyl)-N-methylpentanamide
-
ChemBase ID:
160531
-
Molecular Formular:
C23H43N5O6S
-
Molecular Mass:
517.68242
-
Monoisotopic Mass:
517.29340512
-
SMILES and InChIs
SMILES:
N1[C@@H]2[C@H](NC1=O)[C@@H](SC2)CCCCC(=O)N(CC(=O)NCCCOCCOCCOCCCN)C
Canonical SMILES:
NCCCOCCOCCOCCCNC(=O)CN(C(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1NC(=O)N2)C
InChI:
InChI=1S/C23H43N5O6S/c1-28(21(30)7-3-2-6-19-22-18(17-35-19)26-23(31)27-22)16-20(29)25-9-5-11-33-13-15-34-14-12-32-10-4-8-24/h18-19,22H,2-17,24H2,1H3,(H,25,29)(H2,26,27,31)/t18-,19-,22-/m0/s1
InChIKey:
OCPLNHULTOXKFM-IPJJNNNSSA-N
-
Cite this record
CBID:160531 http://www.chembase.cn/molecule-160531.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]-N-({[3-(2-{2-[3-amino(1,1,2,2-2H4)propoxy]ethoxy}ethoxy)(2,2,3,3-2H4)propyl]carbamoyl}methyl)-N-methylpentanamide
|
|
|
IUPAC Traditional name
|
5-[(3aS,4S,6aR)-2-oxo-hexahydrothieno[3,4-d]imidazolidin-4-yl]-N-({[3-(2-{2-[3-amino(1,1,2,2-2H4)propoxy]ethoxy}ethoxy)(2,2,3,3-2H4)propyl]carbamoyl}methyl)-N-methylpentanamide
|
|
|
Synonyms
|
(3aS,4S,6aR)-N-(16-Amino-2-oxo-7,10,13-trioxa-3-azahexadec-1-yl)hexahydro-N-methyl-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide
|
13-Amino-4,7,10-trioxatridecanyl-2,2',3,3',11,11',12,12'-d8)-N-methyl-N-biotinylglycinamide
|
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
LogD (pH = 5.5)
|
-4.9859004
|
LogD (pH = 7.4)
|
-4.5238185
|
Log P
|
-1.9634409
|
Molar Refractivity
|
135.2811 cm3
|
Polarizability
|
53.161144 Å3
|
Polar Surface Area
|
144.25 Å2
|
Rotatable Bonds
|
20
|
Lipinski's Rule of Five
|
false
|
Acid pKa
|
13.4573965
|
H Acceptors
|
7
|
H Donor
|
4
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
A631852
|
Streptavidin in antibody pretargeting: evaluation of methods for decreasing localization of Streptavidin to kidney while retaining its tumor binding capacity. |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Hnatowich, D., et al.: J. Nucl. Med., 1987, 28, 1294, Sung, C., et al.: Cancer Res., 54, 2166 (1994)
- • Hashmi, M., et al.: Drug Metab. Dispos., 23, 1362 (1994)
- • Pimm, M., et al.: Nucl. Med. Commun., 9, 931 (1994)
- • Alvarez-Diez, T., et al.: Nucl. Med. Biol.
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent